Richard F Burroughs, MD
Dermatology · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 4 carriers
- Offices
- 2
- Since medical school
- 24 years
- University of Vermont College of Medicine, 2002
Offices
2 locations · Pleasanton Allergy and Dermatology Inc · Norman H Epstein MD, John H Epstein MD, and Denny L Tuffanelli MD, Inc
Plans that list them
9 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Burroughs’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
9 of 9 plans
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A85841 · Current
Licensed to practise in California · since 2004 · expires 2028-02-29 · University of Vermont College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$83,485
Medicare paid this office $83,485 for 369 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 241 | $36,668 | $78 |
| Destruction of skin growth, 1-14 growths | 75 | $11,518 | $107 |
| Return visit (30+ min) | 57 | $8,983 | $117 |
| Biopsy of related skin growth, first growth | 60 | $6,481 | $94 |
| New patient visit (30+ min) | 53 | $4,654 | $88 |
See all 10 services
| Short return visit (20+ min) | 241 | $36,668 | $78 |
| Destruction of skin growth, 1-14 growths | 75 | $11,518 | $107 |
| Return visit (30+ min) | 57 | $8,983 | $117 |
| Biopsy of related skin growth, first growth | 60 | $6,481 | $94 |
| New patient visit (30+ min) | 53 | $4,654 | $88 |
| New patient visit (15+ min) | 74 | $4,177 | $56 |
| Short return visit | 41 | $2,718 | $53 |
| Punch biopsy, first skin growth | 17 | $1,866 | $104 |
| New patient visit (45+ min) | 12 | $1,400 | $117 |
| Destruction of precancer skin growth, 1 growth | 15 | $1,293 | $59 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 376 | More than 84% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 139 | More than 80% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of skin growth, 1-14 growths | 56 | 41 | 48 | 59 | 58 | 108 |
| Biopsy of related skin growth, first growth | 58 | 37 | 47 | 56 | 49 | 69 |
| Punch biopsy, first skin growth | – | – | 15 | 19 | 23 | 18 |
| Destruction of precancer skin growth, 1 growth | 15 | – | 13 | – | 14 | 22 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
369 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 16% · Women 52% · Also on Medicaid 59% · Health risk score 1.08. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 62% · Diabetes 28% · Coronary heart disease 19% · Chronic kidney disease 19% · Depression 18% · Atrial fibrillation 14% · Cancer 12% · COPD 11% · Heart failure 9% · Dementia 7% · Stroke 7%.
The office billed $194,908, Medicare allowed $114,518 and paid $83,485; for 1,010 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 369 | 1,010 | 73 | 1.08 | $194,908 | $83,485 |
| 2023 | 288 | 819 | 73 | 0.95 | $157,285 | $63,304 |
| 2022 | 268 | 718 | 73 | 0.99 | $136,583 | $55,491 |
| 2021 | 232 | 653 | 71 | 0.99 | $130,412 | $53,344 |
| 2020 | 202 | 577 | 71 | 1.17 | $111,510 | $42,536 |
| 2019 | 299 | 1,244 | 71 | 1.18 | $168,236 | $64,264 |
| 2018 | 311 | 982 | 71 | 1.22 | $128,358 | $55,939 |
| 2017 | 219 | 653 | 71 | 1.07 | $92,225 | $44,132 |
| 2016 | 94 | 266 | 70 | 1.00 | $43,298 | $21,016 |
| 2015 | 77 | 371 | 69 | 1.11 | $37,137 | $17,576 |
| 2014 | 53 | 176 | 67 | 0.90 | $27,870 | $12,696 |
| 2013 | 100 | 279 | 71 | 1.26 | $36,114 | $18,483 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Short return visit (20+ min) | 196 | $27,842 | $73 |
| Destruction of skin growth, 1-14 growths | 42 | $5,510 | $95 |
| Return visit (30+ min) | 46 | $5,120 | $93 |
| New patient visit (30+ min) | 66 | $4,815 | $73 |
| Biopsy of related skin growth, first growth | 46 | $4,523 | $92 |
| Punch biopsy, first skin growth | 21 | $2,755 | $120 |
| New patient visit (15+ min) | 43 | $2,606 | $61 |
| Short return visit | 27 | $1,539 | $50 |
| Destruction of precancer skin growth, 1 growth | 12 | $641 | $46 |
2022: 8 services
| Short return visit (20+ min) | 182 | $24,969 | $72 |
| Destruction of skin growth, 1-14 growths | 42 | $6,103 | $103 |
| New patient visit (30+ min) | 60 | $4,821 | $80 |
| Biopsy of related skin growth, first growth | 53 | $4,670 | $83 |
| Return visit (30+ min) | 16 | $3,825 | $116 |
| New patient visit (15+ min) | 44 | $2,322 | $53 |
| Punch biopsy, first skin growth | 19 | $2,097 | $110 |
| Short return visit | 21 | $708 | $32 |
2021: 8 services
| Short return visit (20+ min) | 174 | $25,379 | $75 |
| New patient visit (30+ min) | 61 | $5,239 | $86 |
| Destruction of skin growth, 1-14 growths | 35 | $5,151 | $107 |
| Biopsy of related skin growth, first growth | 43 | $4,285 | $91 |
| Punch biopsy, first skin growth | 15 | $1,905 | $127 |
| New patient visit (15+ min) | 22 | $1,262 | $57 |
| Short return visit | 17 | $766 | $40 |
| Destruction of precancer skin growth, 1 growth | 11 | $742 | $57 |
2020: 7 services
| Short return visit (20+ min) | 112 | $13,313 | $56 |
| Return visit (30+ min) | 63 | $8,736 | $90 |
| Destruction of skin growth, 1-14 growths | 27 | $4,008 | $98 |
| New patient visit (45+ min) | 28 | $3,837 | $137 |
| Biopsy of related skin growth, first growth | 34 | $3,169 | $86 |
| New patient visit (30+ min) | 18 | $1,527 | $85 |
| New patient visit (15+ min) | 19 | $1,170 | $62 |
2019: 9 services
| Return visit (30+ min) | 111 | $21,584 | $89 |
| Short return visit (20+ min) | 113 | $11,493 | $56 |
| New patient visit (45+ min) | 43 | $5,686 | $132 |
| Destruction of skin growth, 1-14 growths | 43 | $5,649 | $101 |
| Biopsy of related skin growth, first growth | 54 | $4,755 | $82 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 16 | $3,279 | $102 |
| New patient visit (15+ min) | 40 | $2,030 | $51 |
| Destruction of precancer skin growth, 1 growth | 14 | $881 | $59 |
| Short return visit | 17 | $564 | $31 |
2018: 10 services
| Return visit (30+ min) | 92 | $15,355 | $88 |
| Short return visit (20+ min) | 148 | $12,798 | $51 |
| New patient visit (45+ min) | 44 | $5,292 | $120 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 21 | $5,186 | $68 |
| Destruction of skin growth, 1-14 growths | 37 | $4,545 | $84 |
| Biopsy of single growth of skin and/or tissue | 44 | $4,101 | $82 |
| New patient visit (15+ min) | 36 | $1,789 | $50 |
| Short return visit | 29 | $1,341 | $35 |
| Destruction of precancer skin growth, 1 growth | 16 | $957 | $50 |
| Professional service for preparation and provision of 1 or more antigens | 13 | $725 | $13 |
2017: 8 services
| Return visit (30+ min) | 87 | $15,823 | $82 |
| Short return visit (20+ min) | 102 | $8,190 | $58 |
| Biopsy of single growth of skin and/or tissue | 53 | $5,077 | $89 |
| Destruction of skin growth, 1-14 growths | 32 | $4,011 | $95 |
| New patient visit (45+ min) | 28 | $3,094 | $111 |
| Destruction of precancer skin growth, 1 growth | 15 | $953 | $56 |
| Short return visit | 17 | $750 | $37 |
| Professional service for preparation and provision of 1 or more antigens | 12 | $452 | $12 |
2016: 5 services
| Return visit (30+ min) | 40 | $7,100 | $89 |
| Short return visit (20+ min) | 56 | $4,767 | $60 |
| Biopsy of single growth of skin and/or tissue | 24 | $2,955 | $92 |
| Destruction of skin growth, 1-14 growths | 19 | $2,403 | $100 |
| New patient visit (30+ min) | 21 | $1,433 | $68 |
2015: 4 services
| Short return visit (20+ min) | 55 | $6,217 | $60 |
| New patient visit (30+ min) | 32 | $2,443 | $76 |
| Biopsy of single growth of skin and/or tissue | 19 | $2,313 | $93 |
| Return visit (30+ min) | 17 | $1,678 | $88 |
2014: 3 services
| Short return visit (20+ min) | 39 | $5,684 | $57 |
| Biopsy of single growth of skin and/or tissue | 18 | $1,962 | $89 |
| New patient visit (30+ min) | 20 | $1,343 | $67 |
2013: 5 services
| Short return visit (20+ min) | 63 | $7,879 | $55 |
| Biopsy of single growth of skin and/or tissue | 34 | $3,535 | $96 |
| New patient visit (30+ min) | 16 | $1,175 | $73 |
| New patient visit (15+ min) | 13 | $780 | $60 |
| Short return visit | 17 | $633 | $29 |
Medicaid work
$67,081 in 2024
Medicaid paid $67,081 for 2,779 billed services this clinician did in 2024, up to 110 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 990 | $19,781 |
| Return visit (30+ min) | 368 | $17,069 |
| New patient visit (30+ min) | 626 | $10,893 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 265 | $9,210 |
| Short return visit | 169 | $3,835 |
| New patient visit (45+ min) | 111 | $2,747 |
| Injection, intralesional; up to and including 7 lesions | 130 | $1,630 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 67 | $1,100 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 41 | $817 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 12 | $0 |
| 2024 | 2,779 | 10 | 110 | $67,081 |
| 2023 | 1,946 | 7 | 136 | $42,915 |
| 2022 | 2,035 | 6 | 124 | $46,542 |
| 2021 | 1,725 | 3 | 108 | $36,199 |
| 2020 | 1,403 | 4 | 93 | $41,870 |
| 2019 | 2,258 | 6 | 125 | $77,384 |
| 2018 | 2,055 | 8 | 133 | $46,536 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 1,243 | $25,543 |
| New patient visit (30+ min) | 536 | $13,683 |
| Return visit (30+ min) | 97 | $3,331 |
| Short return visit | 24 | $230 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 15 | $128 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 12 | $0 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 19 | $0 |
2022
| Short return visit (20+ min) | 1,192 | $25,836 |
| New patient visit (30+ min) | 620 | $14,184 |
| Return visit (30+ min) | 163 | $4,480 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 28 | $1,231 |
| New patient visit (45+ min) | 16 | $601 |
| Injection, intralesional; up to and including 7 lesions | 16 | $210 |
2021
| Short return visit (20+ min) | 1,003 | $18,953 |
| New patient visit (30+ min) | 634 | $15,335 |
| Return visit (30+ min) | 88 | $1,911 |
2020
| Return visit (30+ min) | 566 | $18,699 |
| New patient visit (45+ min) | 202 | $10,529 |
| Short return visit (20+ min) | 405 | $6,949 |
| New patient visit (30+ min) | 230 | $5,693 |
2019
| Return visit (30+ min) | 1,504 | $45,735 |
| New patient visit (45+ min) | 440 | $25,429 |
| ACNE SURGERY | 237 | $4,017 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 29 | $1,483 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 34 | $720 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 14 | $0 |
2018
| Return visit (30+ min) | 1,236 | $27,793 |
| New patient visit (45+ min) | 521 | $14,619 |
| Short return visit (20+ min) | 133 | $2,613 |
| New patient visit (30+ min) | 19 | $639 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 28 | $556 |
| New patient visit (60+ min) | 14 | $300 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 21 | $17 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 83 | $0 |
Drugs they prescribed that Part D paid
$620,859
Pharmacies billed $620,859 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,340) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
1,206 generic and 134 brand-name prescriptions · $620,859 in drug cost · 108 antibiotic prescriptions to 58 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 15 | $181,709 | $12,114 |
| Otezla | 12 | $27,421 | $2,285 |
| Vtama | 13 | $18,138 | $1,395 |
| Fluocinonide | 150 | $5,371 | $36 |
| Betamethasone Diprop Augmented | 80 | $4,538 | $57 |
See all 26 drugs
| Humira(Cf) | 15 | $181,709 | $12,114 |
| Otezla | 12 | $27,421 | $2,285 |
| Vtama | 13 | $18,138 | $1,395 |
| Fluocinonide | 150 | $5,371 | $36 |
| Betamethasone Diprop Augmented | 80 | $4,538 | $57 |
| Tacrolimus | 28 | $4,223 | $151 |
| Fluorouracil | 52 | $3,564 | $69 |
| Clindamycin Phosphate | 55 | $3,461 | $63 |
| Clobetasol Propionate | 38 | $2,286 | $60 |
| Ketoconazole | 128 | $2,014 | $16 |
| Erythromycin | 11 | $1,869 | $170 |
| Metronidazole | 21 | $1,376 | $66 |
| Doxycycline Hyclate | 62 | $1,280 | $21 |
| Prednisolone Acetate | 22 | $985 | $45 |
| Triamcinolone Acetonide | 191 | $773 | $4 |
| Tretinoin | 12 | $729 | $61 |
| Betamethasone Dipropionate | 14 | $625 | $45 |
| Nystatin | 50 | $615 | $12 |
| Fluocinolone Acetonide | 12 | $609 | $51 |
| Mupirocin | 49 | $346 | $7 |
| Nystatin-Triamcinolone | 25 | $315 | $13 |
| Clotrimazole | 15 | $225 | $15 |
| Hydrocortisone | 23 | $174 | $8 |
| Amoxicillin-Clavulanate Potass | 19 | $168 | $9 |
| Prednisone | 43 | $138 | $3 |
| Minoxidil | 23 | $97 | $4 |
Year by year
| 2024 | 1,340 | 383 | 0% (0) | 10% | $620,859 |
| 2023 | 1,139 | 311 | 0% (0) | 10% | $442,177 |
| 2022 | 1,019 | 268 | 0% (0) | 9% | $384,634 |
| 2021 | 826 | 233 | 0% (0) | 11% | $236,026 |
| 2020 | 453 | 147 | 0% (0) | 14% | $173,499 |
| 2019 | 544 | 203 | 0% (0) | 17% | $249,774 |
| 2018 | 709 | 249 | 0% (0) | 15% | $215,394 |
| 2017 | 717 | 255 | 0% (0) | 17% | $142,921 |
| 2016 | 559 | 209 | 0% (0) | 15% | $94,261 |
| 2015 | 685 | 213 | 0% (0) | 12% | $66,113 |
| 2014 | 654 | 201 | 0% (0) | 19% | $44,762 |
| 2013 | 624 | 186 | 0% (0) | 24% | $37,654 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Dupixent | 14 | $58,574 | $4,184 |
| Otezla | 11 | $29,555 | $2,687 |
| Fluocinonide | 133 | $7,548 | $57 |
| Betamethasone Diprop Augmented | 94 | $6,305 | $67 |
| Clobetasol Propionate | 32 | $5,191 | $162 |
| Fluorouracil | 37 | $4,133 | $112 |
| Tacrolimus | 16 | $3,212 | $201 |
| Clindamycin Phosphate | 34 | $2,449 | $72 |
| Doxycycline Hyclate | 50 | $2,264 | $45 |
| Ketoconazole | 111 | $2,212 | $20 |
| Doxycycline Monohydrate | 35 | $1,955 | $56 |
| Prednisolone Acetate | 24 | $1,701 | $71 |
| Nystatin-Triamcinolone | 44 | $1,601 | $36 |
| Tretinoin | 13 | $1,363 | $105 |
| Triamcinolone Acetonide | 204 | $1,357 | $7 |
| Minocycline | 12 | $915 | $76 |
| Nystatin | 41 | $622 | $15 |
| Amoxicillin-Clavulanate Potass | 11 | $248 | $23 |
| Mupirocin | 22 | $152 | $7 |
| Prednisone | 11 | $54 | $5 |
| Hydrocortisone | 11 | $52 | $5 |
2022: 21 drugs
| Humira | 11 | $69,257 | $6,296 |
| Pimecrolimus | 20 | $10,060 | $503 |
| Tacrolimus | 27 | $5,613 | $208 |
| Fluocinonide | 101 | $5,278 | $52 |
| Clobetasol Propionate | 42 | $4,630 | $110 |
| Fluorouracil | 36 | $4,124 | $115 |
| Betamethasone Diprop Augmented | 39 | $3,290 | $84 |
| Doxycycline Hyclate | 40 | $2,967 | $74 |
| Minocycline | 11 | $2,197 | $200 |
| Ketoconazole | 78 | $1,525 | $20 |
| Triamcinolone Acetonide | 205 | $1,279 | $6 |
| Nystatin-Triamcinolone | 32 | $1,093 | $34 |
| Doxycycline Monohydrate | 19 | $1,007 | $53 |
| Prednisolone Acetate | 12 | $818 | $68 |
| Nystatin | 42 | $637 | $15 |
| Fluticasone Propionate | 14 | $315 | $22 |
| Amoxicillin-Clavulanate Potass | 13 | $276 | $21 |
| Mupirocin | 23 | $231 | $10 |
| Gabapentin | 21 | $180 | $9 |
| Prednisone | 15 | $90 | $6 |
| Hydrocortisone | 14 | $84 | $6 |
2021: 18 drugs
| Humira | 11 | $64,242 | $5,840 |
| Pimecrolimus | 19 | $8,602 | $453 |
| Tacrolimus | 38 | $8,406 | $221 |
| Fluorouracil | 46 | $5,016 | $109 |
| Fluocinonide | 82 | $4,876 | $59 |
| Doxycycline Hyclate | 39 | $3,029 | $78 |
| Clobetasol Propionate | 25 | $2,546 | $102 |
| Ketoconazole | 80 | $2,189 | $27 |
| Betamethasone Dipropionate | 25 | $1,735 | $69 |
| Betamethasone Diprop Augmented | 20 | $1,476 | $74 |
| Triamcinolone Acetonide | 160 | $1,070 | $7 |
| Metronidazole | 12 | $906 | $76 |
| Doxycycline Monohydrate | 22 | $832 | $38 |
| Nystatin-Triamcinolone | 14 | $374 | $27 |
| Nystatin | 21 | $334 | $16 |
| Mupirocin | 22 | $169 | $8 |
| Hydrocortisone | 18 | $88 | $5 |
| Prednisone | 13 | $56 | $4 |
2020: 11 drugs
| Tacrolimus | 16 | $6,117 | $382 |
| Fluocinonide | 55 | $3,240 | $59 |
| Fluorouracil | 21 | $2,529 | $120 |
| Betamethasone Diprop Augmented | 21 | $1,872 | $89 |
| Doxycycline Hyclate | 30 | $1,682 | $56 |
| Betamethasone Dipropionate | 17 | $1,506 | $89 |
| Nystatin-Triamcinolone | 17 | $690 | $41 |
| Ketoconazole | 33 | $670 | $20 |
| Triamcinolone Acetonide | 97 | $560 | $6 |
| Mupirocin | 19 | $250 | $13 |
| Hydroxyzine | 11 | $60 | $5 |
2019: 13 drugs
| Humira | 16 | $82,731 | $5,171 |
| Otezla | 13 | $45,963 | $3,536 |
| Fluocinonide | 61 | $3,626 | $59 |
| Fluorouracil | 26 | $3,010 | $116 |
| Betamethasone Dipropionate | 29 | $2,370 | $82 |
| Doxycycline Hyclate | 37 | $2,295 | $62 |
| Ketoconazole | 45 | $1,297 | $29 |
| Nystatin-Triamcinolone | 15 | $888 | $59 |
| Triamcinolone Acetonide | 113 | $850 | $8 |
| Betamethasone Diprop Augmented | 12 | $846 | $71 |
| Mupirocin | 32 | $327 | $10 |
| Prednisone | 14 | $69 | $5 |
| Hydroxyzine | 14 | $62 | $4 |
2018: 17 drugs
| Humira | 15 | $73,710 | $4,914 |
| Otezla | 13 | $46,976 | $3,614 |
| Fluocinonide | 101 | $6,573 | $65 |
| Fluorouracil | 31 | $3,445 | $111 |
| Betamethasone Dipropionate | 40 | $3,271 | $82 |
| Fluocinolone Acetonide | 22 | $3,259 | $148 |
| Doxycycline Hyclate | 21 | $1,595 | $76 |
| Nystatin-Triamcinolone | 19 | $1,470 | $77 |
| Betamethasone Diprop Augmented | 14 | $1,450 | $104 |
| Triamcinolone Acetonide | 159 | $1,358 | $9 |
| Ketoconazole | 53 | $1,086 | $20 |
| Clindamycin Phosphate | 15 | $945 | $63 |
| Fluticasone Propionate | 15 | $599 | $40 |
| Mupirocin | 39 | $414 | $11 |
| Nystatin | 14 | $169 | $12 |
| Hydrocortisone | 11 | $99 | $9 |
| Prednisone | 17 | $79 | $5 |
2017: 16 drugs
| Clobetasol Propionate | 42 | $6,411 | $153 |
| Fluocinonide | 82 | $5,486 | $67 |
| Fluorouracil | 45 | $5,179 | $115 |
| Elidel | 11 | $3,376 | $307 |
| Doxycycline Hyclate | 36 | $1,931 | $54 |
| Metronidazole | 15 | $1,929 | $129 |
| Ketoconazole | 66 | $1,651 | $25 |
| Nystatin-Triamcinolone | 14 | $1,636 | $117 |
| Prednisolone Acetate | 18 | $1,452 | $81 |
| Betamethasone Dipropionate | 22 | $1,442 | $66 |
| Triamcinolone Acetonide | 129 | $866 | $7 |
| Mupirocin | 38 | $347 | $9 |
| Minocycline | 12 | $252 | $21 |
| Erythromycin | 11 | $169 | $15 |
| Nystatin | 11 | $82 | $7 |
| Prednisone | 11 | $53 | $5 |
2016: 9 drugs
| Clobetasol Propionate | 74 | $13,508 | $183 |
| Fluocinonide | 82 | $5,598 | $68 |
| Fluorouracil | 26 | $3,426 | $132 |
| Doxycycline Hyclate | 26 | $3,353 | $129 |
| Nystatin-Triamcinolone | 23 | $3,306 | $144 |
| Ketoconazole | 63 | $1,732 | $27 |
| Triamcinolone Acetonide | 67 | $499 | $7 |
| Mupirocin | 25 | $288 | $12 |
| Hydrocortisone | 12 | $76 | $6 |
2015: 13 drugs
| Clobetasol Propionate | 87 | $17,192 | $198 |
| Fluocinonide | 81 | $4,996 | $62 |
| Clindamycin Phosphate | 33 | $4,158 | $126 |
| Doxycycline Hyclate | 35 | $3,895 | $111 |
| Desonide | 32 | $3,164 | $99 |
| Fluorouracil | 20 | $3,127 | $156 |
| Nystatin-Triamcinolone | 17 | $2,082 | $122 |
| Fluocinolone Acetonide | 13 | $1,951 | $150 |
| Ketoconazole | 89 | $1,902 | $21 |
| Triamcinolone Acetonide | 99 | $802 | $8 |
| Mupirocin | 43 | $424 | $10 |
| Clindamycin | 11 | $125 | $11 |
| Prednisone | 17 | $102 | $6 |
2014: 12 drugs
| Clobetasol Propionate | 65 | $5,650 | $87 |
| Desonide | 62 | $4,897 | $79 |
| Doxycycline Hyclate | 30 | $3,959 | $132 |
| Nystatin-Triamcinolone | 32 | $2,993 | $94 |
| Fluocinonide | 65 | $2,696 | $41 |
| Fluorouracil | 13 | $2,423 | $186 |
| Clindamycin Phosphate | 16 | $1,555 | $97 |
| Ketoconazole | 70 | $1,269 | $18 |
| Mupirocin | 67 | $891 | $13 |
| Triamcinolone Acetonide | 99 | $690 | $7 |
| Clindamycin | 18 | $194 | $11 |
| Prednisone | 16 | $136 | $9 |
2013: 15 drugs
| Calcipotriene | 14 | $5,155 | $368 |
| Doxycycline Hyclate | 30 | $3,036 | $101 |
| Fluorouracil | 14 | $2,710 | $194 |
| Cordran | 11 | $2,282 | $207 |
| Desonide | 65 | $2,184 | $34 |
| Clindamycin Phosphate | 22 | $2,046 | $93 |
| Fluocinonide | 59 | $1,425 | $24 |
| Ketoconazole | 73 | $1,295 | $18 |
| Nystatin-Triamcinolone | 13 | $1,070 | $82 |
| Clobetasol Propionate | 55 | $1,058 | $19 |
| Mupirocin | 52 | $691 | $13 |
| Tretinoin | 15 | $578 | $39 |
| Triamcinolone Acetonide | 67 | $455 | $7 |
| Dicloxacillin | 12 | $217 | $18 |
| Clindamycin | 11 | $192 | $17 |
Money from drug and device companies
$2,748 in 2025
| 2025 | 17 | 160 | None | $2,748 |
| 2024 | 20 | 194 | None | $3,734 |
| 2023 | 16 | 162 | None | $2,976 |
| 2022 | 19 | 161 | None | $2,898 |
| 2021 | 12 | 88 | None | $1,377 |
| 2020 | 11 | 19 | None | $387 |
| 2019 | 19 | 60 | None | $1,185 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | Bimzelx | $365 | 17 payments
|
| Abbvie | Skyrizi | $345 | 21 payments
|
| Incyte | Opzelura | $292 | 24 payments
|
| Galderma Laboratories L.P. | Nemluvio | $279 | 15 payments
|
| Arcutis Biotherapeutics | Zoryve | $230 | 13 payments
|
| Genzyme | Dupixent | $204 | 11 payments
|
See all 157 published payments
| Pfizer | Meals · 2025-12-11 | Litfulo | $25 |
| Galderma Laboratories L.P. | Meals · 2025-12-10 | Nemluvio | $7 |
| Genzyme | Meals · 2025-11-24 | Dupixent | $12 |
| Incyte | Meals · 2025-11-20 | Opzelura | $14 |
| LEO Pharma | Meals · 2025-11-20 | Spevigo | $20 |
| LEO Pharma | Meals · 2025-11-20 | Spevigo | $9 |
| Ucb | Meals · 2025-11-18 | Bimzelx | $24 |
| LEO Pharma | Meals · 2025-11-14 | Spevigo | $17 |
| Galderma Laboratories L.P. | Meals · 2025-11-13 | Nemluvio | $14 |
| Novartis Pharmaceuticals | Meals · 2025-11-12 | Cosentyx | $16 |
| Abbvie | Meals · 2025-11-12 | Rinvoq | $23 |
| Abbvie | Meals · 2025-11-11 | Skyrizi | $17 |
| Incyte | Meals · 2025-11-11 | Opzelura | $23 |
| Incyte | Meals · 2025-11-04 | Opzelura | $10 |
| Pfizer | Meals · 2025-11-04 | Litfulo | $25 |
| Galderma Laboratories L.P. | Meals · 2025-11-04 | Nemluvio | $26 |
| Incyte | Meals · 2025-10-31 | Opzelura | $21 |
| LEO Pharma | Meals · 2025-10-28 | Adbry | $17 |
| Journey Medical | Meals · 2025-10-27 | None | $22 |
| Novartis Pharmaceuticals | Meals · 2025-10-22 | Rhapsido | $27 |
| Incyte | Meals · 2025-10-22 | Opzelura | $12 |
| Organon | Meals · 2025-10-22 | Vtama | $3 |
| Galderma Laboratories L.P. | Meals · 2025-10-21 | Nemluvio | $34 |
| Incyte | Meals · 2025-10-16 | Opzelura | $12 |
| Galderma Laboratories L.P. | Meals · 2025-10-15 | Nemluvio | $10 |
| Janssen Biotech | Meals · 2025-10-13 | Tremfya | $25 |
| Galderma Laboratories L.P. | Meals · 2025-10-10 | Nemluvio | $8 |
| Novartis Pharmaceuticals | Meals · 2025-10-08 | Rhapsido | $27 |
| Arcutis Biotherapeutics | Meals · 2025-10-08 | Zoryve | $13 |
| Abbvie | Meals · 2025-10-01 | Skyrizi | $27 |
| Organon | Meals · 2025-09-29 | None | $7 |
| Pfizer | Meals · 2025-09-26 | Litfulo | $28 |
| Genzyme | Meals · 2025-09-26 | Dupixent | $11 |
| Incyte | Meals · 2025-09-25 | Opzelura | $8 |
| Janssen Biotech | Meals · 2025-09-24 | Tremfya | $30 |
| Cipher Pharmaceuticals US | Meals · 2025-09-23 | Natroba | $23 |
| Arcutis Biotherapeutics | Meals · 2025-09-22 | Zoryve | $32 |
| Ucb | Meals · 2025-09-18 | Bimzelx | $26 |
| LEO Pharma | Meals · 2025-09-17 | Adbry | $8 |
| Incyte | Meals · 2025-09-16 | Opzelura | $6 |
| Pfizer | Meals · 2025-09-16 | Litfulo | $26 |
| Janssen Biotech | Meals · 2025-09-12 | Tremfya | $18 |
| Abbvie | Meals · 2025-09-12 | Rinvoq | $22 |
| Genzyme | Meals · 2025-09-12 | Dupixent | $26 |
| Ucb | Meals · 2025-09-11 | Bimzelx | $26 |
| Incyte | Meals · 2025-09-08 | Opzelura | $6 |
| Arcutis Biotherapeutics | Meals · 2025-09-08 | Zoryve | $17 |
| Ucb | Meals · 2025-09-03 | Bimzelx | $25 |
| Galderma Laboratories L.P. | Meals · 2025-08-28 | Nemluvio | $17 |
| LEO Pharma | Meals · 2025-08-27 | Adbry | $8 |
| Lilly USA | Meals · 2025-08-26 | Taltz | $22 |
| Abbvie | Meals · 2025-08-25 | Skyrizi | $22 |
| Arcutis Biotherapeutics | Meals · 2025-08-21 | Zoryve | $23 |
| Incyte | Meals · 2025-08-20 | Opzelura | $17 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-19 | Spevigo | $34 |
| Pfizer | Meals · 2025-08-16 | Litfulo | $15 |
| Genzyme | Meals · 2025-08-15 | Dupixent | $13 |
| Galderma Laboratories L.P. | Meals · 2025-08-14 | Nemluvio | $9 |
| Arcutis Biotherapeutics | Meals · 2025-08-14 | Zoryve | $28 |
| Verrica Pharmaceuticals | Meals · 2025-08-13 | Ycanth | $21 |
| Ucb | Meals · 2025-08-13 | Bimzelx | $20 |
| Galderma Laboratories L.P. | Meals · 2025-08-13 | None | $2 |
| Incyte | Meals · 2025-08-05 | Opzelura | $24 |
| Abbvie | Meals · 2025-08-01 | Skyrizi | $10 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-01 | Spevigo | $19 |
| Galderma Laboratories L.P. | Meals · 2025-07-29 | Nemluvio | $6 |
| Lilly USA | Meals · 2025-07-28 | Taltz | $23 |
| Abbvie | Meals · 2025-07-25 | Rinvoq | $18 |
| Ucb | Meals · 2025-07-23 | Bimzelx | $23 |
| Incyte | Meals · 2025-07-22 | Opzelura | $9 |
| Arcutis Biotherapeutics | Meals · 2025-07-21 | Zoryve | $14 |
| LEO Pharma | Meals · 2025-07-15 | Adbry | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-14 | Spevigo | $32 |
| Pfizer | Meals · 2025-07-10 | Litfulo | $11 |
| Ucb | Meals · 2025-07-09 | Bimzelx | $20 |
| Genzyme | Meals · 2025-06-27 | Dupixent | $32 |
| Galderma Laboratories L.P. | Meals · 2025-06-27 | Nemluvio | $40 |
| Abbvie | Meals · 2025-06-23 | Skyrizi | $9 |
| Arcutis Biotherapeutics | Meals · 2025-06-18 | Zoryve | $9 |
| Ucb | Meals · 2025-06-17 | Bimzelx | $5 |
| Arcutis Biotherapeutics | Meals · 2025-06-16 | Zoryve | $20 |
| Incyte | Meals · 2025-06-10 | Opzelura | $6 |
| Incyte | Meals · 2025-06-06 | Opzelura | $18 |
| Incyte | Meals · 2025-06-06 | Opzelura | $9 |
| LEO Pharma | Meals · 2025-06-04 | Adbry | $15 |
| Abbvie | Meals · 2025-06-03 | Skyrizi | $9 |
| Galderma Laboratories L.P. | Meals · 2025-06-03 | Nemluvio | $24 |
| Abbvie | Meals · 2025-05-28 | Rinvoq | $9 |
| Incyte | Meals · 2025-05-28 | Opzelura | $27 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-21 | Spevigo | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-21 | Spevigo | $16 |
| Arcutis Biotherapeutics | Meals · 2025-05-21 | Zoryve | $13 |
| LEO Pharma | Meals · 2025-05-20 | Adbry | $13 |
| Pfizer | Meals · 2025-05-16 | Litfulo | $27 |
| Abbvie | Meals · 2025-05-13 | Skyrizi | $5 |
| Incyte | Meals · 2025-05-13 | Opzelura | $5 |
| Ucb | Meals · 2025-05-08 | Bimzelx | $23 |
| Incyte | Meals · 2025-05-06 | Opzelura | $5 |
| Incyte | Meals · 2025-05-06 | Opzelura | $1 |
| Galderma Laboratories L.P. | Meals · 2025-04-30 | Nemluvio | $31 |
| Incyte | Meals · 2025-04-24 | Opzelura | $6 |
| Genzyme | Meals · 2025-04-24 | Dupixent | $22 |
| Galderma Laboratories L.P. | Meals · 2025-04-24 | Nemluvio | $30 |
| Ucb | Meals · 2025-04-21 | Bimzelx | $6 |
| Abbvie | Meals · 2025-04-17 | Skyrizi | $23 |
| Abbvie | Meals · 2025-04-16 | Rinvoq | $29 |
| Pfizer | Meals · 2025-04-16 | Litfulo | $9 |
| LEO Pharma | Meals · 2025-04-15 | Adbry | $15 |
| LEO Pharma | Meals · 2025-04-15 | Adbry | $11 |
| Abbvie | Meals · 2025-04-08 | Skyrizi | $11 |
| Incyte | Meals · 2025-04-08 | Opzelura | $23 |
| Ucb | Meals · 2025-04-03 | Bimzelx | $15 |
| Janssen Biotech | Meals · 2025-04-02 | Tremfya | $23 |
| Genzyme | Meals · 2025-04-02 | Dupixent | $10 |
| Genzyme | Meals · 2025-04-01 | Dupixent | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-25 | Sotyktu | $17 |
| Genzyme | Meals · 2025-03-25 | Dupixent | $11 |
| Arcutis Biotherapeutics | Meals · 2025-03-24 | Zoryve | $30 |
| Incyte | Meals · 2025-03-20 | Opzelura | $20 |
| Lilly USA | Meals · 2025-03-19 | Taltz | $26 |
| Janssen Biotech | Meals · 2025-03-18 | Tremfya | $26 |
| LEO Pharma | Meals · 2025-03-18 | Adbry | $10 |
| Ucb | Meals · 2025-03-12 | Bimzelx | $22 |
| Galderma Laboratories L.P. | Meals · 2025-03-11 | Nemluvio | $21 |
| Ucb | Meals · 2025-03-07 | Bimzelx | $21 |
| Arcutis Biotherapeutics | Meals · 2025-03-06 | Zoryve | $19 |
| Abbvie | Meals · 2025-03-05 | Skyrizi | $19 |
| Lilly USA | Meals · 2025-03-04 | Taltz | $6 |
| Lilly USA | Meals · 2025-02-25 | Taltz | $31 |
| LEO Pharma | Meals · 2025-02-25 | Adbry | $10 |
| LEO Pharma | Meals · 2025-02-25 | Adbry | $2 |
| Genzyme | Meals · 2025-02-24 | Dupixent | $8 |
| Ucb | Meals · 2025-02-13 | Bimzelx | $25 |
| Ucb | Meals · 2025-02-11 | Bimzelx | $27 |
| Ucb | Meals · 2025-02-07 | Bimzelx | $31 |
| Lilly USA | Meals · 2025-02-06 | Taltz | $5 |
| Abbvie | Meals · 2025-02-06 | Skyrizi | $12 |
| Organon | Meals · 2025-02-05 | Vtama | $13 |
| Organon | Meals · 2025-02-05 | Vtama | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-29 | Sotyktu | $22 |
| Incyte | Meals · 2025-01-29 | Opzelura | $4 |
| Incyte | Meals · 2025-01-29 | Opzelura | $5 |
| Janssen Biotech | Meals · 2025-01-28 | Tremfya | $19 |
| Arcutis Biotherapeutics | Meals · 2025-01-28 | Zoryve | $6 |
| Organon | Meals · 2025-01-25 | Vtama | $22 |
| Pfizer | Meals · 2025-01-23 | Litfulo | $27 |
| Abbvie | Meals · 2025-01-22 | Rinvoq | $28 |
| Abbvie | Meals · 2025-01-21 | Skyrizi | $14 |
| Abbvie | Meals · 2025-01-16 | Rinvoq | $19 |
| Genzyme | Meals · 2025-01-15 | Dupixent | $32 |
| LEO Pharma | Meals · 2025-01-15 | Adbry | $9 |
| Lilly USA | Meals · 2025-01-14 | Taltz | $32 |
| Abbvie | Meals · 2025-01-14 | Skyrizi | $8 |
| Lilly USA | Meals · 2025-01-13 | Taltz | $5 |
| Abbvie | Education · 2025-01-10 | None | $10 |
| Ucb | Meals · 2025-01-08 | Bimzelx | $26 |
| Arcutis Biotherapeutics | Meals · 2025-01-06 | Zoryve | $6 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,734
| Abbvie | Skyrizi | $1,272 | 71 payments
|
| Genzyme | Dupixent | $332 | 16 payments
|
| Lilly USA | Taltz | $312 | 14 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $281 | 10 payments
|
| Pfizer | Litfulo | $194 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $167 | 4 payments
|
| Janssen Biotech | Tremfya | $157 | 6 payments
|
| Amgen | Otezla | $150 | 8 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $148 | 7 payments
|
| Incyte | Opzelura | $145 | 14 payments
|
| Arcutis Biotherapeutics | Zoryve | $138 | 9 payments
|
| Dermavant Sciences | Vtama | $105 | 5 payments
|
| Galderma Laboratories L.P. | None | $80 | 3 payments
|
| LEO Pharma | Adbry | $65 | 4 payments
|
| Sun Pharmaceutical Industries | Ilumya | $53 | 2 payments
|
| Ucb | Bimzelx | $42 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $27 | 1 payment
|
| Teva Pharmaceuticals USA | Simlandi | $22 | 1 payment
|
| Fresenius Kabi USA | Idacio | $22 | 1 payment
|
| Almirall | Klisyri | $22 | 1 payment
|
2023: $2,976
| AbbVie | Skyrizi | $842 | 48 payments
|
| Lilly USA | Taltz | $364 | 19 payments
|
| Amgen | Otezla | $286 | 17 payments
|
| LEO Pharma | Adbry | $206 | 21 payments
|
| Dermavant Sciences | Vtama | $191 | 9 payments
|
| Genzyme | Dupixent | $188 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $186 | 8 payments
|
| Pfizer | Cibinqo | $177 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $135 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $106 | 4 payments
|
| Janssen Biotech | Tremfya | $95 | 2 payments
|
| Fresenius Kabi USA | Idacio | $50 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $47 | 2 payments
|
| Organogenesis | Puraply | $40 | 1 payment
|
| Sun Pharmaceutical Industries | Odomzo | $32 | 1 payment
|
| Mylan Institutional | Hulio | $30 | 1 payment
|
2022: $2,898
| Abbvie | Skyrizi | $820 | 53 payments
|
| LEO Pharma | Adbry | $335 | 27 payments
|
| Ucb | Cimzia | $310 | 10 payments
|
| Janssen Biotech | Remicade | $245 | 13 payments
|
| Lilly USA | Taltz | $210 | 10 payments
|
| Regeneron Healthcare Solutions | Dupixent | $179 | 10 payments
|
| Novartis Pharmaceuticals | Cosentyx | $176 | 12 payments
|
| Genzyme | Dupixent | $147 | 6 payments
|
| Amgen | Otezla | $89 | 4 payments
|
| Incyte | Opzelura | $72 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $52 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $51 | 2 payments
|
| Pfizer | Cibinqo | $48 | 2 payments
|
| Galderma Laboratories L.P. | Twyneo | $44 | 2 payments
|
| EPI Health | Cloderm | $25 | 1 payment
|
| Kyowa Kirin | Poteligeo | $25 | 1 payment
|
| Genentech USA | Erivedge | $25 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $24 | 1 payment
|
| Dermavant Sciences | Vtama | $22 | 1 payment
|
2021: $1,377
| AbbVie | Skyrizi | $642 | 46 payments
|
| LEO Pharma | Enstilar | $155 | 15 payments
|
| Pfizer | Eucrisa | $122 | 5 payments
|
| Lilly USA | Taltz | $117 | 7 payments
|
| Janssen Biotech | Remicade | $112 | 5 payments
|
| Novartis Pharmaceuticals | Cosentyx | $62 | 3 payments
|
| Galderma Laboratories L.P. | Aklief | $37 | 2 payments
|
| Ucb | Cimzia | $31 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $27 | 1 payment
|
| Incyte | Opzelura | $25 | 1 payment
|
| Genzyme | Dupixent | $25 | 1 payment
|
| Sun Pharmaceutical Industries | Blu-U | $23 | 1 payment
|
2020: $387
| AbbVie | Skyrizi | $66 | 3 payments
|
| Janssen Biotech | Remicade | $59 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $49 | 2 payments
|
| Lilly USA | Taltz | $47 | 2 payments
|
| Pfizer | Eucrisa | $36 | 2 payments
|
| LEO Pharma | Enstilar | $35 | 2 payments
|
| VYNE Pharmaceuticals | Amzeeq | $26 | 1 payment
|
| Genzyme | Dupixent | $24 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $20 | 1 payment
|
| Galderma Laboratories L.P. | Soolantra | $13 | 1 payment
|
| Helsinn Therapeutics (U.S.) | Valchlor | $12 | 1 payment
|
2019: $1,185
| Pfizer | Eucrisa | $190 | 14 payments
|
| Janssen Biotech | Tremfya | $137 | 4 payments
|
| AbbVie | Skyrizi | $127 | 6 payments
|
| Lilly USA | Taltz | $118 | 5 payments
|
| Galderma Laboratories L.P. | Epiduo Forte | $92 | 5 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $83 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $67 | 3 payments
|
| Celgene | Otezla | $57 | 3 payments
|
| Genentech USA | Erivedge | $50 | 2 payments
|
| Sandoz | Kerydin | $48 | 3 payments
|
| Amgen | Enbrel | $48 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $33 | 2 payments
|
| Mylan Pharmaceuticals | Olux | $24 | 1 payment
|
| Ucb | Cimzia | $23 | 1 payment
|
| Biofrontera | Ameluz | $21 | 1 payment
|
| Merck Sharp & Dohme | Sivextro | $19 | 1 payment
|
| Genzyme | Dupixent | $18 | 1 payment
|
| Journey Medical | Exelderm | $15 | 1 payment
|
| Merz North America | Xeomin | $13 | 1 payment
|
Professional record
- NPI
- 1649250101
- Licence
- CA A85841California A85841: Current · expires 2028-02-29
- Trained
- University of Vermont College of Medicine, 2002 · 24 years ago
- Group
- Pleasanton Allergy and Dermatology Inc · Norman H Epstein MD, John H Epstein MD, and Denny L Tuffanelli MD, Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 463 Wyndgate Rd, Sacramento, CA, 95864
- NPI first listed
- 2006-01-20
- NPI last updated
- 2011-01-27
This is when the NPI record was last certified, not a medical board exam.